Multidrug therapy in paucibacillary leprosy--a five year experience.

Simple item page
dc.contributor.authorGrugni, Aen_US
dc.contributor.authorNadkarni, N Jen_US
dc.contributor.authorKini, M Sen_US
dc.date.accessioned1988-10-01en_US
dc.date.accessioned2009-05-28T10:06:51Z
dc.date.available1988-10-01en_US
dc.date.available2009-05-28T10:06:51Z
dc.date.issued1988-10-01en_US
dc.description.abstract736 paucibacillary (PB) patients were given multidrug therapy (MDT) for at least 6 months. Overall, 44% became inactive after 6 doses, and 69% after 12 doses. However, 27% remained active at the time of analysis. It is recommended that at least 12 doses of MDT be given to PB patients irrespective of the type.en_US
dc.description.affiliationLok Seva Sangam, D-1, Everard Nagar, Bombay.en_US
dc.identifier.citationGrugni A, Nadkarni NJ, Kini MS. Multidrug therapy in paucibacillary leprosy--a five year experience. Indian Journal of Leprosy. 1988 Oct; 60(4): 589-92en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/54867
dc.language.isoengen_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshChilden_US
dc.subject.meshDapsone --administration & dosageen_US
dc.subject.meshDrug Therapy, Combinationen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshLeprosy --drug therapyen_US
dc.subject.meshMaleen_US
dc.subject.meshProspective Studiesen_US
dc.subject.meshRifampin --administration & dosageen_US
dc.titleMultidrug therapy in paucibacillary leprosy--a five year experience.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Indian Journal of Leprosy